Wagas, Segundina .

HRN: 28-62-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/01/2026
03/08/2026
IV
4.5mg Then 2.5mg
Now Then Q8
Ulcer
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines